Selective Chemokine Receptor-Targeted Depletion of Pathological Cells as a Therapeutic Strategy for Inflammatory, Allergic and Autoimmune Diseases

Recent Patents on Inflammation and Allergy Drug Discovery- United Arab Emirates

doi 10.2174/187221309789257423

Full Text

Abstract

Available in

Date

Authors

Publisher

Bentham Science Publishers Ltd.

Related search

The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases

Frontiers in Immunology
AllergyImmunology
2016English

AB0458 B Cells Depletion for the Treatment of Systemic Autoimmune Diseases

2017English

Pharmacogenetics: A Strategy for Personalized Medicine for Autoimmune Diseases

Clinical Genetics
Genetics
2018English

Erratum: TNF Defined as a Therapeutic Target for Rheumatoid Arthritis and Other Autoimmune Diseases

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2003English

Commensal Gut-Derived Anaerobes as Novel Therapy for Inflammatory Autoimmune Diseases

2012English

Manipulation of Endogenous Neural Stem Cells as a Therapeutic Strategy for Neurodegenerative Diseases: Insights From Animal Models

2013English

Utilizing TH9 Cells as a Novel Therapeutic Strategy for Malignancies

OncoImmunology
OncologyAllergyImmunology
2013English

Selective Depletion of Alloreactive T Cells by Targeted Therapy of Heat Shock Protein 90: A Novel Strategy for Control of Graft-Versus-Host Disease

Blood
BiochemistryImmunologyCell BiologyHematology
2009English

Polyvalent Dendrimer-Methotrexate as a Folate Receptor-Targeted Cancer Therapeutic

Molecular Pharmaceutics
Drug DiscoveryMolecular MedicinePharmaceutical Science
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy